We nest examined the effect of CPE on HT29 CRC cells carrying BRAFV600E mutation/wild type RAS and HCT116 CRC cells carrying wild type BRAF and KRASG13D mutation [20,21] (Figure 6). The gene discussed is BRAF; the disease is colorectal carcinoma.